Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

6 курс / Кардиология / Омега_3_полиненасыщенные_жирные_кислоты_в_современной_кардиологической

.pdf
Скачиваний:
0
Добавлен:
24.03.2024
Размер:
4.25 Mб
Скачать

Sanderson P., Calder P.C. Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers // Immunology. – 1998. – V.94, N.1. – P. 79–87.

Sandesara С.М., Chung M.K. van Wagoner D.R. et al. A Randomized, Pla- cebo–Controlled Trial of Omega–3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial // J. Am. Heart Assoc. – 2012. – V.1, N.3. – P. e000547

Sandker G.W., Kromhout D., Aravanis C. et al. Serum cholesteryl ester fatty acids and their relation with serum lipids in elderly men in Crete and The Netherlands // Eur. J. Clin. Nutr. – 1993. – V.47, N.3. – P. 201–208.

Saravanan P., Bridgewater B., West A. L. et al. Omega–3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double– blind, placebo– controlled clinical trial // Circ. Arrhythm. Electrophysiol. – 2010. – V.3, N.1. – P. 46–53.

von Schacky C. Omega–3 fatty acids: antiarrhythmic, proarrhythmic or both?// Curr. Opin. Clin. Nutr. Metab. Care. – 2008. – V.11, N.2. – P. 94–99.

von Schacky C. Omega–3 Fatty acids: anti– arrhythmic, pro– arrhythmic, or both? // Front Physiol. – 2012. – V.3. – P.88.

von Schacky C. The role of omega–3 fatty acids in cardiovascular disease // Curr. Atheroscler. Rep. – 2003. – V.5, N.2. – P. 139–145.,

von Schacky C., Harris W.S. Cardiovascular benefits of omega–3 fatty acids // Cardiovasc. Res. – 2007. – V.73, N.2. – P. 310–315.

Schmidt E.B., Koenig W., Khuseyinova N., Christensen J.H. Lipoprotein– associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n–3 fatty acids // Atherosclerosis. – 2008. – V.196, N.1. – P. 420–424

Schmidt E.B., Skou H.A., Christensen J.H., Dyerberg J. N–3 fatty acids from fish and coronary artery disease: implications for public health // Public health nutrition. – 2000. – V.3, N.1. – P. 91–98.

Seikikawa A., Curb J.D., Ueshima H. Marine–derived n–3 fatty acids and atherosclerosis in Japanese, Japanese–American, and white men: a cross–sectional study // J. Am. Coll. Cardiol. – 2008. – V.52, N.6. – P. 417–424.

Sekikawa A., Horiuchi B.Y., Edmundowicz D. et al. A «natural experiment» in cardiovascular epidemiology in the early 21st century // Heart. – 2003. – V.89, N.3. – P. 255–257.

Sekikawa A., KullerL.H. Coronary heart disease mortality in the United States among black and white men 35–44 years old by state // CVD Prev. – 1999. – V.2. – P. 212–221.

Sekikawa A., Ueshima H., Kadowaki T. et al. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post– World War II birth cohort // Am. J. Epidemiol. – 2007. – V.165, N.6. – P. 617– 624.

~ 151 ~

Sellmayer A., Witzgall H., Lorenz R.L., Weber P.C. Effects of dietary fish oil on ventricular premature complexes // Am. J. Cardiol. – 1995. – V.76, N.12. – P. 974–977.

Shen J., Johnson V.M., Sullivan L.M. et al. Dietary factors and incident atrial fibrillation: the Framingham Heart Study // Am. J. Clin. Nutr. – 2011. – V.93, N.2. – P. 261–236.

Simopoulos A.P. Evolutionary Aspects of Nutrition and Health. Diet, Exercise, Genetics and Chronic Disease // World. Rev. Nutr. Diet. – 1999. – V.84: P. 1– 146.

Simopoulos A.P. The importance of the omega–6/omega–3 fatty acid ratio in cardiovascular disease and other chronic diseases // Exp. Biol. Med. (Maywood). 2008. – V.233, N.6. – P. 674–88.

Simopoulos A.P. The Mediterranean diets: what is so special about the diet of Greece // J. Nutr. – 2001. – V.131, Suppl. 11. – P. 3065S–3073S.

Simopoulos A.P., Kifer R.R., Martin R.E., Barlow S.M.. Health effects of polyunsaturated fatty acid in seafood's // World Rev. Nutr. Diet. – 1991. – V.66, N.1. – P. 592.

Sinclair H.M. Deficiency of essential fatty acids and atherosclerosis, etcetera. (Letter to the editor.) // Lancet. – 1956. – V.1. – P. 381–383.

Sinclair Н.М. The diet of Canadian Indians and Eskimos // Proc. Nutr. Soc. – 1953. – V.12. – P. 69–82.

Singer P, Wirth M. Can omega–3 polyunsaturated fatty acids reduce cardiac arrhythmias? Results of a clinical trial // Prostaglandins Leukot. Essent. Fatty Acids. – 2004. – V.71, N.3. – P. 153–159.

Singer P., Wirth M. Can n–3 PUFA reduce cardiac arrhythmias? Results of a clinical trial // Prostaglandins, Leukotrienes and Essential Fatty Acids. – 2004. – V.71, N.3. – P. 153–159.

Singh R.B., Dubnov G., Niaz M.A. et al. Effect of an Indo–Mediterranean diet on progression of coronary artery disease in high risk patients (Indo– Mediterranean Diet Heart Study): a randomised single–blind trial // Lancet. – 2002. – V.360, N. 9344. – P. 1455–1461.

Singh R.B., Niaz M.A., Sharma J.P. et al. Randomized, double – blinde, placebo – controlled trial of fish oil and mustard oil in patients with suspected Acute myocardial infarction: the Indian experiment of infarct survival–4 // Cardiovasc. Drugs. Then. – 1997. – V.11, N.3. – P. 485–491

Siscovick D.S., Lemaitre R.N., Mozaffarian D. The fish story. A diet–heart hypothesis with clinical implications: n–3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death // Circulation. – 2003. – V.107, N.21. – P. 2632–2634.

Siscovick D.S., Raghunathan Т.Е., King I. et al. Dietary intake and cell membrane levels of long–chain n–3 polyunsaturated fatty acids and the risk of primary cardiac arrest // J. Am. Med. Assoc. – 1995. – V.274, N.17. – P. 1363–1367.

~ 152 ~

Skou H.A., Toft E., Christensen J.H. et al. N–3 fatty acids and cardiac function after myocardial infarction in Denmark // Int. J. Circumpolar. Health. – 2001. – V.60, N.3. – P. 360–365.

Skuladottir G.V., Heidarsdottir R., Arnar D.O. et al. Plasma n– 3 and n– 6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery // Eur. J. Clin. Invest. – 2011. – V.41, N.9. – P. 995–1003.

Smith G.D., Brion M.J., Sterne J.A. N–3 polyunsaturated fatty acids and statins in heart failure // Lancet. – 2009. – V.373, N.9661. – P. 378.

Smith P.J., Blumenthal J.A., Babyak M.A. et al. Association between n– 3 fatty acid consumption and ventricular ectopy after myocardial infarction // Am. J. Clin. Nutr. – 2009. – V.89, N.5. – P. 1315–1320.

Solfrizzi V., Capurso C., Vendemiale G. et al. N–3 polyunsaturated fatty acids and statins in heart failure // Lancet. – 2009. – V.373, N.9661. – P. 380. Stefansson V. The Fat of the Land. – New York: Macmillan Press, 1960 – 339 p.

Stone N.J. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)–Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors // Curr. Cardiol. Rep. – 2000. –V.2, N.5. – P. 445–451.

Streppel M.T., Ocké M.C., Boshuizen H.C. et al. Long– term fish consumption and n– 3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study // Eur. Heart. J. – 2008. – V.29, N.16. – P. 2024–2030.

Strøm M., Halldorsson T.I., Mortensen E.L. et al. Fish, n–3 fatty acids, and cardiovascular diseases in women of reproductive age: a prospective study in a large national cohort // Hypertension. – 2012. – V.59, N.1. – P. 36–43

Studer M, Briel M, Leimenstoll B. et al. Effect of different antilipidemic agents and diets on mortality //Arch. intern. Med. – 2005. – V.165, N.7. – P. 725–730.

Takei H., Strong J.P., Yutani C., Malcom G.T. Comparison of coronary and aortic atherosclerosis in youth from Japan and the USA // Atherosclerosis. – 2005. – V.180, N.1. – P. 171–179.

Tanaka K., Ishikawa Y., Yokoyama M. et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial // Stroke. – 2008. – V.39, N.7. – P. 2052–2058.

Tavazzi L., Tognoni G., Franzosi MG. et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n–3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure // Eur. J. Heart. Fail. – 2004. - V.6, N.5. – P. 635–641.

Tilley S.L., Coffman T.M., Koller B.H. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes // J. Clin. Invest. – 2001. – V.108, N.1. – P. 15–23.

Tinoco J. Dietary requirements and functions of –linolenic acid in animals // Prog Lipid Res. – 1982. – V.21, N.1. – P. 1–45.

~ 153 ~

Toshima H., Koga Y., Menotti A. et al. The seven countries study in Japan. Twenty–five–year experience in cardiovascular and all–causes deaths // Jpn. Heart J. – 1995. – V.36, N.2. – P. 179–189.

Trichopoulou A., Bamia C., Trichopoulos D. Mediterranean diet and survival among patients with coronary heart disease in Greece // Arch. Intern. Med. – 2005. – V.165, N.8. – P. 929–935.

Trichopoulou A., Costacou T., Bamia C., Trichopoulos D.N. Adherence to a Mediterranean Diet and Survival in a Greek Population. // N. Engl. J. Med. – 2003. – V.348, N.26. – P. 2599–2608

Verschuren W.M., Jacobs D.R., Bloemberg B.P. et al. Serum total cholesterol and long–term coronary heart disease mortality in different cultures. Twenty– five–year follow–up of the seven countries study // JAMA. – 1995. – V.274, N.2. – P. 131–136.

Vincent–Baudry S., Defoort C., Gerber M. et al. The Medi–RIVAGE study: reduction of cardiovascular disease risk factors after a 3–mo intervention with a Mediterranean–type diet or a low–fat diet // Am. J. Clin. Nutr. – 2005. – V.82, N.5. – P. 964–971.

Virtanen J.K., Mursu J., Voutilainen S. et al. Serum long– chain n– 3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men // Circulation. 2009. – V.120, N.23. – P. 2315–2323.

Vismara L.A., Amsterdam B.A., Mason D.T. Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge // Am. J. Med. – 1975. – V.59, N.1. – P. 6–12.

Viviani Anselmi C., Ferreri C., Novelli V. et al. Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls // J. Interv. Card. Electrophysiol. – 2010. – V.27, N.2. – P. 95–99.

Watanabe E., Sobue Y., Sano K. et al. Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation // Ann. Noninvasive Electrocardiol. – 2011. – V.16, N.4. – P. 373–378.

Wennberg M., Bergdahl I.A., Stegmayr B. et al. Fish intake, mercury, long– chain n–3 polyunsaturated fatty acids and risk of stroke in northern Sweden // Br. J. Nutr. – 2007 – V.98, N.5. – P. 1038–1045.

Westerveld H.T., de Graaf I.C., van Breugel HHFI, et al. Effects of low– dose EPA–E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM // Diabetes Care. - 1993. – V.16, N.5. - P. 683–688.

Wilhelm M., Tobias R., Asskali F. et al. Red blood cell omega– 3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure // Am. Heart J. – 2008. – V.155, N.6. – P. 971–977.

Willett W.C., Sacks F., Trichopoulou A. et al. Mediterranean diet pyramid: a cultural model for healthy eating // Am. J. Clin. Nutr. – 1995. – V.61. Suppl. 6.

– P. 1402S–1406S

~ 154 ~

William H. Omega–3 fatty acids: the «Japanese» factor? // J. Am. Coll. Cardiol.

– 2008. – V.52, N.6. – P. 425–427.

Wu J. H., Lemaitre R. N., King I. B. et al. Association of plasma phospholipid long– chain omega– 3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study // Circulation. – 2012. – V.125, N.9. – P. 1084– 1093.

Yamagishi K., Iso H., Date C. et al. Fish, omega–3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community–based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study // J. Am. Coll. Cardiol. – 2008a. – V.52, N.12. – P. 988–996

Yamagishi K., Nettleton J.A., Folsom A.R. Plasma fatty acid composition and incident heart failure in middle–aged adults: the Atherosclerosis Risk In Communities (ARIC) study // Am. Heart. J. – 2008b. – V.156, N.5. – P. 967–974 Yokoyama M., Origasa H. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS) // Am. Heart. J. – 2003.– V.146, N.4. – P. 613–620.

Yokoyama M., Origasa H., Matsuzaki M. et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open–label, blinded endpoint analysis // Lancet. – 2007. – V.369, N.9567. – P.1090–1098.

Yuan J.M., Ross R.K., Gao Y.T., Yu M.C. Fish and shellfish consumption inrelation to death from myocardial infarction among men in Shanghai, China // Am. J. Epidemiol. – 2001. – V.154, N.9. – P. 809–816.

Zampelas A., Panagiotakos D.B., Pitsavos C. et al. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study // Am. Coll. Cardiol. – 2005. – V46, N.1. P. – 120–124.

Zhao G., Etherton T.D., Martin K.R. et al. Dietary alpha–linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women // J. Nutr. – 2004. – V.134, N.11. – P. 2991–2997.

~ 155 ~

Научное издание:

Гоголашвили Николай Гамлетович Яскевич Роман Анатольевич Литвиненко Мария Викторовна Новгородцева Наталья Яковлевна Поликарпов Леонид Севастьянович

Омега-3 полиненасыщенные жирные кислоты в современной кардиологической практике